The IV catheters market was valued at $8.6 billion in 2022 and is estimated to reach $17.8 billion by 2032, exhibiting a CAGR of 7.5% from 2023 to 2032. An intravenous (IV) catheter, also known as an IV line or IV cannula, is a medical device used to administer fluids, medications, or blood products directly into a patient's bloodstream. It consists of a thin, flexible tube typically made of plastic or other biocompatible materials with a sharp needle or catheter at one end. The needle is used to puncture a vein, and once the catheter is in place, the needle is removed, leaving the catheter securely in the vein.
The major factors driving the growth of the IV catheters market are the increase in the number of people suffering from chronic conditions, rise in geriatric population, and continuous advancements in IV catheters. The surge in prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and infectious diseases drives the demand for IV catheters. Intravenous administration allows for the direct and efficient delivery of medications, fluids, and nutrition, making it a crucial treatment method for patients with chronic conditions.
In addition, ongoing technological advancements in IV catheter designs, materials, insertion techniques, and related medical equipment have made IV therapy more efficient, comfortable, and safe, which is expected to drive the market growth. Innovations encourage healthcare providers to utilize IV catheters for a broader range of treatments, further driving the market expansion.
Further, the trend toward home-based healthcare and outpatient services has increased the use of IV catheters outside traditional hospital settings, thereby driving the market growth. Patients with chronic conditions or those requiring post-operative care may receive IV therapy at home, leading to higher demand.
However, the risk of complications and infections and stringent regulatory requirements are the factors that hamper the growth of IV catheters market. The use of intravenous equipment carries a certain degree of risk, including the potential for complications and infections. Improper insertion, handling, or maintenance of IV catheters may lead to catheter-related bloodstream infections (CRBSIs) or other complications such as phlebitis or infiltration, thereby restraining the market growth. However, the growing aging population, increase in surgical procedures, and rise in technological advancements are expected to offer opportunities to the key players of the market.
The IV catheters market is segmented into product, type, end user, and region. By product, the market is classified into 18 G, 20G, 22G, 24 G, and others. By type, the market is classified into peripheral IV catheters, central venous catheters, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, Malaysia, Thailand, Philippines, Singapore, Indonesia, Vietnam, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the global IV catheters market are Becton Dickinson & Company, B Braun SE, AngioDynamics, Inc., Terumo Corporation, Poly Medicure Ltd., Teleflex Incorporated, Vygon, BL Group of Companies, and ICU Medical Inc. Key players operating in the market have adopted acquisition, product launch and others as their key strategies to expand their product portfolio.
The major factors driving the growth of the IV catheters market are the increase in the number of people suffering from chronic conditions, rise in geriatric population, and continuous advancements in IV catheters. The surge in prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and infectious diseases drives the demand for IV catheters. Intravenous administration allows for the direct and efficient delivery of medications, fluids, and nutrition, making it a crucial treatment method for patients with chronic conditions.
In addition, ongoing technological advancements in IV catheter designs, materials, insertion techniques, and related medical equipment have made IV therapy more efficient, comfortable, and safe, which is expected to drive the market growth. Innovations encourage healthcare providers to utilize IV catheters for a broader range of treatments, further driving the market expansion.
Further, the trend toward home-based healthcare and outpatient services has increased the use of IV catheters outside traditional hospital settings, thereby driving the market growth. Patients with chronic conditions or those requiring post-operative care may receive IV therapy at home, leading to higher demand.
However, the risk of complications and infections and stringent regulatory requirements are the factors that hamper the growth of IV catheters market. The use of intravenous equipment carries a certain degree of risk, including the potential for complications and infections. Improper insertion, handling, or maintenance of IV catheters may lead to catheter-related bloodstream infections (CRBSIs) or other complications such as phlebitis or infiltration, thereby restraining the market growth. However, the growing aging population, increase in surgical procedures, and rise in technological advancements are expected to offer opportunities to the key players of the market.
The IV catheters market is segmented into product, type, end user, and region. By product, the market is classified into 18 G, 20G, 22G, 24 G, and others. By type, the market is classified into peripheral IV catheters, central venous catheters, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, Malaysia, Thailand, Philippines, Singapore, Indonesia, Vietnam, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the global IV catheters market are Becton Dickinson & Company, B Braun SE, AngioDynamics, Inc., Terumo Corporation, Poly Medicure Ltd., Teleflex Incorporated, Vygon, BL Group of Companies, and ICU Medical Inc. Key players operating in the market have adopted acquisition, product launch and others as their key strategies to expand their product portfolio.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the iv catheters market analysis from 2022 to 2032 to identify the prevailing iv catheters market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the iv catheters market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global iv catheters market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
- 18G
- 20G
- 22G
- 24G
- Others
By Type
- Others
- Peripheral IV Catheters
- Central Venous Catheters
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Malaysia
- Thailand
- Philippines
- Singapore
- Indonesia
- Vietnam
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- ICU Medical Inc.
- Terumo Corporation
- Vygon
- Becton, Dickinson and Company
- Nipro Corporation
- B. Braun SE
- AngioDynamics, Inc.
- Teleflex Incorporated
- Poly Medicure Ltd.
- BL Group of Companies
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: IV CATHETERS MARKET, BY PRODUCT
CHAPTER 5: IV CATHETERS MARKET, BY TYPE
CHAPTER 6: IV CATHETERS MARKET, BY END USER
CHAPTER 7: IV CATHETERS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
The IV Catheters Market is likely to experience a significant growth rate of 7.5% from 2023-2032 owing to an increase in demand for IV catheters from the medical devices and supplies sector.An intravenous (IV) catheter is a medical device used in healthcare for the administration of fluids, medications, blood products, or other treatments. It is a thin, flexible tube typically made of plastic, rubber, or other biocompatible materials. IV catheters are inserted directly into a vein, allowing healthcare professionals to deliver substances directly into the circulatory system.
Key factors driving the growth of the IV catheters market include the increase in prevalence of chronic and diseases, surge in number of surgical procedures, rise in the technological advancements in intravenous equipment and rise in awareness about early disease diagnosis. For instance, according to the National Center for Biotechnology Information (NCBI) in 2023, around 1,958,310 new cancer cases are estimated to occur in the U.S.
Rise in the prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer drives the market growth in this region. These conditions often require long-term treatments that involve the use of IV catheters for medication administration and fluid management, which is the major factor that drives the IV catheters market growth. For instance, according to an article published by National Center for Biotechnology and Information (NCBI) in 2022, about 21% of the elderly in India reportedly have at least one chronic disease. Thus, increase in incidence of chronic diseases surges the need for intravenous catheters.
In addition, rise in the technological advancements led to the development of IV equipment with enhanced safety features, reducing the risk of complications and improving patient safety, which supports the market growth. Safety-engineered IV catheters, such as the BD Nexiva Closed IV Catheter System, incorporate mechanisms such as retractable needles or self-sealing ports to minimize the risk of needlestick injuries and protect healthcare workers from potential infections.
Furthermore, rise in the number of surgical procedures is a key driver of the IV catheters market growth. Many surgical procedures, whether they are major surgeries or minor interventions, require intravenous access. IV catheters are essential for delivering fluids, anesthesia, medications, and other critical substances directly into the patient's bloodstream during surgery.
The market also offers growth opportunities to the key players in the market. Emerging markets present significant growth opportunities for various industries, including the healthcare sector and the market for IV catheters. Many emerging markets are investing in healthcare infrastructure development such as the construction of hospitals, clinics, and healthcare facilities. This expansion creates a greater demand for medical devices such as IV catheters thereby providing lucrative opportunities for market growth.
The IV catheters market is segmented into product, type, end user, and region. On the basis of product, the market is categorized into 18G, 20G, 22G, 24G, and others. By type, the market is classified peripheral IV catheters, central venous catheters, and others. Depending on the end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, Malaysia, Thailand, Philippines, Singapore, Indonesia, Vietnam, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The key players profiled in the study include Becton Dickinson & Company, B Braun SE, AngioDynamics, Inc., Terumo Corporation, Poly Medicure Ltd., Teleflex Incorporated, Vygon, BL Group of Companies, and ICU Medical Inc. The players in the market have been actively engaged in the adoption of various strategies such as acquisition, product launch and others to remain competitive and gain an advantage over the competitors in the market. For instance, in June 2022, Teleflex Incorporated announced the launch of an Arrow Pressure Injectable Midline Catheter in Europe, the Middle East, and Africa regions. The addition of the pressure injectable catheter further enhances the Midline portfolio to meet the expanded needs of clinicians and is designed to improve patient safety.
Key Market Insights
By product, the 22G segment was the largest revenue contributor to the market and is estimated to reach $4.4 billion by 2032. However, the 24G segment is anticipated to grow at the highest CAGR of 8.2% during the forecast period.By type, the peripheral IV catheters segment dominated the global market in 2022. However, the central venous catheters segment is anticipated to grow at the highest CAGR of 7.9% during the forecast period.
Based on end user, the hospitals segment was the largest revenue contributor to the market and expected to register the highest CAGR during the forecast period.
Based on region, North America garnered the largest revenue share in 2022, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- ICU Medical Inc.
- Terumo Corporation
- Vygon
- Becton, Dickinson and Company
- Nipro Corporation
- B. Braun SE
- AngioDynamics, Inc.
- Teleflex Incorporated
- Poly Medicure Ltd.
- BL Group of Companies
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
